Specialty Retail
Compare Stocks
4 / 10Stock Comparison
YSG vs SKIN vs ELF vs COTY
Revenue, margins, valuation, and 5-year total return — side by side.
Household & Personal Products
Household & Personal Products
Household & Personal Products
YSG vs SKIN vs ELF vs COTY — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Specialty Retail | Household & Personal Products | Household & Personal Products | Household & Personal Products |
| Market Cap | $299M | $118M | $3.44B | $2.20B |
| Revenue (TTM) | $4.07B | $296M | $1.52B | $5.79B |
| Net Income (TTM) | $-479M | $-6M | $104M | $-536M |
| Gross Margin | 78.3% | 64.9% | 70.3% | 61.9% |
| Operating Margin | -3.9% | -3.6% | 11.1% | -0.3% |
| Forward P/E | 5.1x | — | 19.6x | 8.2x |
| Total Debt | $149M | $379M | $313M | $4.25B |
| Cash & Equiv. | $817M | $233M | $149M | $257M |
YSG vs SKIN vs ELF vs COTY — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| Yatsen Holding Limi… (YSG) | 100 | 3.5 | -96.5% |
| The Beauty Health C… (SKIN) | 100 | 5.7 | -94.3% |
| e.l.f. Beauty, Inc. (ELF) | 100 | 279.9 | +179.9% |
| Coty Inc. (COTY) | 100 | 34.4 | -65.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: YSG vs SKIN vs ELF vs COTY
Each card shows where this stock fits in a portfolio — not just who wins on paper.
YSG is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.38, Low D/E 4.8%, current ratio 3.67x
- Beta 1.38, current ratio 3.67x
- Lower P/E (5.1x vs 8.2x)
SKIN lags the leaders in this set but could rank higher in a more targeted comparison.
ELF carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 28.3%, EPS growth -13.1%, 3Y rev CAGR 49.6%
- 133.1% 10Y total return vs COTY's -83.0%
- 28.3% revenue growth vs SKIN's -10.0%
- 6.8% margin vs YSG's -11.8%
COTY is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 1 yrs, beta 1.08, yield 0.6%
- Beta 1.08 vs ELF's 2.36
- 0.6% yield; 1-year raise streak; the other 3 pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 28.3% revenue growth vs SKIN's -10.0% | |
| Value | Lower P/E (5.1x vs 8.2x) | |
| Quality / Margins | 6.8% margin vs YSG's -11.8% | |
| Stability / Safety | Beta 1.08 vs ELF's 2.36 | |
| Dividends | 0.6% yield; 1-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | -7.2% vs COTY's -45.3% | |
| Efficiency (ROA) | 4.5% ROA vs YSG's -12.0%, ROIC 13.5% vs -10.9% |
YSG vs SKIN vs ELF vs COTY — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
YSG vs SKIN vs ELF vs COTY — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ELF leads in 3 of 6 categories
COTY leads 2 • YSG leads 0 • SKIN leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
ELF leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
COTY is the larger business by revenue, generating $5.8B annually — 19.6x SKIN's $296M. ELF is the more profitable business, keeping 6.8% of every revenue dollar as net income compared to YSG's -11.8%. On growth, YSG holds the edge at +50.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $4.1B | $296M | $1.5B | $5.8B |
| EBITDAEarnings before interest/tax | -$60M | $9M | $235M | $314M |
| Net IncomeAfter-tax profit | -$479M | -$6M | $104M | -$536M |
| Free Cash FlowCash after capex | $0 | $29M | $215M | $311M |
| Gross MarginGross profit ÷ Revenue | +78.3% | +64.9% | +70.3% | +61.9% |
| Operating MarginEBIT ÷ Revenue | -3.9% | -3.6% | +11.1% | -0.3% |
| Net MarginNet income ÷ Revenue | -11.8% | -2.0% | +6.8% | -9.3% |
| FCF MarginFCF ÷ Revenue | -8.7% | +9.8% | +14.1% | +5.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +50.0% | -6.7% | +37.8% | -1.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +40.7% | +38.0% | +116.7% | 0.0% |
Valuation Metrics
COTY leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, COTY's 9.4x EV/EBITDA is more attractive than SKIN's 7331.2x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $299M | $118M | $3.4B | $2.2B |
| Enterprise ValueMkt cap + debt − cash | $200M | $264M | $3.6B | $6.2B |
| Trailing P/EPrice ÷ TTM EPS | -2.87x | -5.69x | 32.18x | -5.68x |
| Forward P/EPrice ÷ next-FY EPS est. | 5.11x | — | 19.60x | 8.17x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.79x | — |
| EV / EBITDAEnterprise value multiple | — | 7331.15x | 17.85x | 9.36x |
| Price / SalesMarket cap ÷ Revenue | 0.59x | 0.39x | 2.62x | 0.37x |
| Price / BookPrice ÷ Book value/share | 0.66x | 2.02x | 4.74x | 0.55x |
| Price / FCFMarket cap ÷ FCF | — | 3.17x | 29.86x | 7.93x |
Profitability & Efficiency
ELF leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ELF delivers a 8.9% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-15 for YSG. YSG carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to SKIN's 6.20x. On the Piotroski fundamental quality scale (0–9), SKIN scores 7/9 vs YSG's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -15.5% | -9.4% | +8.9% | -14.1% |
| ROA (TTM)Return on assets | -12.0% | -1.2% | +4.5% | -4.7% |
| ROICReturn on invested capital | -10.9% | -6.8% | +13.5% | +2.3% |
| ROCEReturn on capital employed | -11.1% | -4.5% | +16.6% | +2.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.05x | 6.20x | 0.41x | 1.07x |
| Net DebtTotal debt minus cash | -$668M | $146M | $164M | $4.0B |
| Cash & Equiv.Liquid assets | $817M | $233M | $149M | $257M |
| Total DebtShort + long-term debt | $149M | $379M | $313M | $4.2B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.81x | 6.48x | 0.23x |
Total Returns (Dividends Reinvested)
ELF leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ELF five years ago would be worth $20,505 today (with dividends reinvested), compared to $624 for YSG. Over the past 12 months, ELF leads with a -7.2% total return vs COTY's -45.3%. The 3-year compound annual growth rate (CAGR) favors ELF at -11.8% vs SKIN's -56.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -30.4% | -35.0% | -20.6% | -19.6% |
| 1-Year ReturnPast 12 months | -31.4% | -35.9% | -7.2% | -45.3% |
| 3-Year ReturnCumulative with dividends | -33.6% | -91.7% | -31.4% | -79.4% |
| 5-Year ReturnCumulative with dividends | -93.8% | -92.9% | +105.0% | -75.8% |
| 10-Year ReturnCumulative with dividends | -96.8% | -91.6% | +133.1% | -83.0% |
| CAGR (3Y)Annualised 3-year return | -12.7% | -56.4% | -11.8% | -40.9% |
Risk & Volatility
COTY leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
COTY is the less volatile stock with a 1.08 beta — it tends to amplify market swings less than ELF's 2.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. COTY currently trades 46.8% from its 52-week high vs YSG's 25.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.41x | 1.71x | 2.27x | 1.13x |
| 52-Week HighHighest price in past year | $11.57 | $2.69 | $150.99 | $5.34 |
| 52-Week LowLowest price in past year | $2.64 | $0.76 | $58.05 | $1.96 |
| % of 52W HighCurrent price vs 52-week peak | +25.5% | +33.8% | +40.9% | +46.8% |
| RSI (14)Momentum oscillator 0–100 | 39.9 | 52.1 | 42.3 | 70.6 |
| Avg Volume (50D)Average daily shares traded | 141K | 760K | 2.3M | 7.9M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: YSG as "Hold", SKIN as "Hold", ELF as "Buy", COTY as "Hold". Consensus price targets imply 56.0% upside for COTY (target: $4) vs 42.9% for SKIN (target: $1). COTY is the only dividend payer here at 0.61% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | — | $1.30 | $95.17 | $3.90 |
| # AnalystsCovering analysts | 3 | 13 | 27 | 33 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.6% |
| Dividend StreakConsecutive years of raises | — | — | 1 | 1 |
| Dividend / ShareAnnual DPS | — | — | — | $0.02 |
| Buyback YieldShare repurchases ÷ mkt cap | +20.0% | 0.0% | +1.9% | 0.0% |
ELF leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). COTY leads in 2 (Valuation Metrics, Risk & Volatility).
YSG vs SKIN vs ELF vs COTY: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is YSG or SKIN or ELF or COTY a better buy right now?
For growth investors, e.
l. f. Beauty, Inc. (ELF) is the stronger pick with 28. 3% revenue growth year-over-year, versus -10. 0% for The Beauty Health Company (SKIN). e. l. f. Beauty, Inc. (ELF) offers the better valuation at 32. 2x trailing P/E (19. 6x forward), making it the more compelling value choice. Analysts rate e. l. f. Beauty, Inc. (ELF) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — YSG or SKIN or ELF or COTY?
On forward P/E, Yatsen Holding Limited is actually cheaper at 5.
1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — YSG or SKIN or ELF or COTY?
Over the past 5 years, e.
l. f. Beauty, Inc. (ELF) delivered a total return of +105. 0%, compared to -93. 8% for Yatsen Holding Limited (YSG). Over 10 years, the gap is even starker: ELF returned +129. 7% versus YSG's -96. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — YSG or SKIN or ELF or COTY?
By beta (market sensitivity over 5 years), Coty Inc.
(COTY) is the lower-risk stock at 1. 13β versus e. l. f. Beauty, Inc. 's 2. 27β — meaning ELF is approximately 101% more volatile than COTY relative to the S&P 500. On balance sheet safety, Yatsen Holding Limited (YSG) carries a lower debt/equity ratio of 5% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.
05Which is growing faster — YSG or SKIN or ELF or COTY?
By revenue growth (latest reported year), e.
l. f. Beauty, Inc. (ELF) is pulling ahead at 28. 3% versus -10. 0% for The Beauty Health Company (SKIN). On earnings-per-share growth, the picture is similar: The Beauty Health Company grew EPS 55. 6% year-over-year, compared to -609. 8% for Coty Inc.. Over a 3-year CAGR, ELF leads at 49. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — YSG or SKIN or ELF or COTY?
e.
l. f. Beauty, Inc. (ELF) is the more profitable company, earning 8. 5% net margin versus -20. 9% for Yatsen Holding Limited — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ELF leads at 12. 0% versus -12. 4% for YSG. At the gross margin level — before operating expenses — YSG leads at 77. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is YSG or SKIN or ELF or COTY more undervalued right now?
On forward earnings alone, Yatsen Holding Limited (YSG) trades at 5.
1x forward P/E versus 19. 6x for e. l. f. Beauty, Inc. — 14. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for COTY: 56. 0% to $3. 90.
08Which pays a better dividend — YSG or SKIN or ELF or COTY?
In this comparison, COTY (0.
6% yield) pays a dividend. YSG, SKIN, ELF do not pay a meaningful dividend and should not be held primarily for income.
09Is YSG or SKIN or ELF or COTY better for a retirement portfolio?
For long-horizon retirement investors, Coty Inc.
(COTY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 13), 0. 6% yield). e. l. f. Beauty, Inc. (ELF) carries a higher beta of 2. 27 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (COTY: -83. 1%, ELF: +129. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between YSG and SKIN and ELF and COTY?
These companies operate in different sectors (YSG (Consumer Cyclical) and SKIN (Consumer Defensive) and ELF (Consumer Defensive) and COTY (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: YSG is a small-cap quality compounder stock; SKIN is a small-cap quality compounder stock; ELF is a small-cap high-growth stock; COTY is a small-cap quality compounder stock. COTY pays a dividend while YSG, SKIN, ELF do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.